Cargando…
Lipocalin 2 contributes to brain iron dysregulation but does not affect cognition, plaque load, and glial activation in the J20 Alzheimer mouse model
BACKGROUND: Lipocalin 2 (Lcn2) is an acute-phase protein implicated in multiple neurodegenerative conditions. Interestingly, both neuroprotective and neurodegenerative effects have been described for Lcn2. Increased Lcn2 levels were found in human post-mortem Alzheimer (AD) brain tissue, and in vitr...
Autores principales: | Dekens, Doortje W., Naudé, Petrus J. W., Keijser, Jan N., Boerema, Ate S., De Deyn, Peter P., Eisel, Ulrich L. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267886/ https://www.ncbi.nlm.nih.gov/pubmed/30501637 http://dx.doi.org/10.1186/s12974-018-1372-5 |
Ejemplares similares
-
Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer’s Disease (AD) Brain Regions: Differential Findings in AD with and without Depression
por: Dekens, Doortje W., et al.
Publicado: (2016) -
The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration
por: Ortí-Casañ, Natalia, et al.
Publicado: (2023) -
Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer’s Disease
por: Ortí-Casañ, Natalia, et al.
Publicado: (2019) -
A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer’s disease mouse model
por: Ortí-Casañ, Natalia, et al.
Publicado: (2022) -
Modulation of Glial and Neuronal Migration by Lipocalin-2 in Zebrafish
por: Kim, Ho, et al.
Publicado: (2011)